Intratumor injected gold molecular clusters for NIR-II imaging and cancer therapy
Proceedings of the National Academy of Sciences · 30.01.2024 · 121 (5)
DOI: 10.1073/pnas.2318265121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 23.01.2024. Verfasst von Ani Baghdasaryan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Bio-X, Stanford University, Stanford, CA 94305. Hauptthemen laut MEDLINE: Breast Neoplasms, Mammary Neoplasms, Animal. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, HHS | National Institutes of Health.
Abstract (Originalsprache)
Surgical resections of solid tumors guided by visual inspection of tumor margins have been performed for over a century to treat cancer. Near-infrared (NIR) fluorescence labeling/imaging of tumor in the NIR-I (800 to 900 nm) range with systemically administrated fluorophore/tumor-targeting antibody conjugates have been introduced to improve tumor margin delineation, tumor removal accuracy, and patient survival. Here, we show Au 25 molecular clusters functionalized with phosphorylcholine ligands (AuPC, ~2 nm in size) as a preclinical intratumorally injectable agent for NIR-II/SWIR (1,000 to 3,000 nm) fluorescence imaging-guided tumor resection. The AuPC clusters were found to be uniformly distributed in the 4T1 murine breast cancer tumor upon intratumor (i.t.) injection. The phosphocholine coating afforded highly stealth clusters, allowing a high percentage of AuPC to fill the tumor interstitial fluid space homogeneously. Intra-operative surgical navigation guided by imaging of the NIR-II fluorescence of AuPC allowed for complete and non-excessive tumor resection. The AuPC in tumors were also employed as a photothermal therapy (PTT) agent to uniformly heat up and eradicate tumors. Further, we performed in vivo NIR-IIb (1,500 to 1,700 nm) molecular imaging of the treated tumor using a quantum dot-Annexin V (QD-P 3 -Anx V) conjugate, revealing cancer cell apoptosis following PTT. The therapeutic functionalities of AuPC clusters combined with rapid renal excretion, high biocompatibility, and safety make them promising for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Bio-X, Stanford University, Stanford, CA 94305.
- Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford University, Stanford, CA 94305.
ORCID-Profile: Ani Baghdasaryan, Lilit Grigoryan
Förderung
- NINDS NIH HHS
- HHS | National Institutes of Health
Zitieren
APA
Baghdasaryan, A., Liu, H., Ren, F., Hsu, R., Jiang, Y., Wang, F., Zhang, M., Grigoryan, L., & Dai, H. (2024). Intratumor injected gold molecular clusters for NIR-II imaging and cancer therapy. Proceedings of the National Academy of Sciences, 121(5). https://doi.org/10.1073/pnas.2318265121
Vancouver
Baghdasaryan A, Liu H, Ren F, Hsu R, Jiang Y, Wang F, et al. Intratumor injected gold molecular clusters for NIR-II imaging and cancer therapy. Proceedings of the National Academy of Sciences. 2024;121(5). doi:10.1073/pnas.2318265121
BibTeX
@article{Baghdasaryan2024,
author = {Baghdasaryan, Ani and Liu, Haoran and Ren, Fuqiang and Hsu, RuSiou and Jiang, Yingying and Wang, Feifei and Zhang, Mengzhen and Grigoryan, Lilit and Dai, Hongjie},
title = {Intratumor injected gold molecular clusters for NIR-II imaging and cancer therapy},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {5},
doi = {10.1073/pnas.2318265121}
}
EUVIMED